paclitaxel
Commercial- Indications
- Metastatic breast cancer
Company intelligence / Profile preview
Abraxis BioScience
Los Angeles, California, United Statesabraxisbioscience.in ↗
- Ownership
- Private
- Employees
- ~800
- Development stage
- Commercial
01
Overview
Abraxis BioScience developed Abraxane®, a nanoparticle albumin-bound formulation of paclitaxel approved for metastatic breast cancer. Clinical trials showed improved progression-free survival versus standard therapies with fewer side effects. At the time of its acquisition by Celgene, Abraxane was also being studied in multiple solid tumor indications including lung and pancreatic cancers. The company’s proprietary nab™ technology platform enabled targeted delivery of chemotherapeutic agents using human albumin as a carrier.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculesNanoparticle albumin-bound drug delivery systems
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
AstraZeneca (previously for marketing)Specialised Therapeutics Australia (licensing agreement for regional commercialization)
Beyond the preview
Go deeper on Abraxis BioScience.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abraxis BioScience.